“President Obama’s new initiative to fund genetic sequencing could be a powerful tool for good in improving U.S. health care—but only if the medical establishment welcomes it.” That’s the view of Duke Chancellor Emeritus, Ralph Snyderman, MD in a recent article in The American Interest. In the article, he explains, “On January 30, 2015, President […]
Category: Personalized Medicine
Ralph Snyderman, M.D. ORIGINAL SOURCE Ten years ago, the sequencing of the entire human genome, along with the development of aggregate “omics” technologies began giving rise to a fundamentally new capability for the practice of medicine – the ability to predict and track disease risks on a personalized basis, to understand diseases mechanistically, and to […]
